Cryo-Cell International Inc.

CCEL Healthcare Medical Care Facilities

Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024. In the quarter to August 2026, revenue was flat, EPS grew 77.8%, free cash flow fell 58.4% and total debt fell 29.5%, each against the same quarter a year earlier.

4.42 0.77 +21.10%
Market cap
$29.4M
P/E
0.0×
Fwd P/E
43.8×
Dividend yield
0.00%
F-score
6/9
Altman Z
−0.23
Beneish M
−3.17
Dividend safety
20/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Nov '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 Nov '19 Nov '18 Nov '17 Nov '16
Total current assets
11.76 12.55 9.45 9.61 15.78 18.56 15.39 14.76 12.74 9.01
Total non-current assets
49.97 52.12 51.77 55.28 44.88 27.64 27.50 27.63 11.17 10.53
Total Assets
61.73 64.68 61.22 64.89 60.66 46.20 42.89 42.39 23.91 19.54
Total current liabilities
19.79 21.60 20.86 19.48 21.07 16.41 15.43 15.43 13.94 13.11
Total non-current liabilities
60.54 56.29 51.39 46.93 35.40 32.45 34.41 35.87 22.47 21.84
Total liabilities
80.33 77.89 72.25 66.41 56.48 48.87 49.84 51.30 36.41 34.95
Common Equity (Total)
(18.61) (13.22) (11.03) (1.52) 4.18 (2.67) (6.95) (8.91) (12.50) (15.41)
Shareholders Equity (Total)
(18.61) (13.22) (11.03) (1.52) 4.18 (2.67) (6.95) (8.91) (12.50) (15.41)
Total Debt
10.47 11.83 9.65 10.85 2.82 6.22 8.96 12.94 7.30 9.82

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 15 Oct 2026